| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |